Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by EC Aiello
Budget Impact Analysis of the Introduction of Saxagliptin/Metformin Extended-Release (Xr) in the Treatment of Type-2 Diabetes in Chile
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Saxagliptin/Metformin Extended-Release (XR) for the Type 2 Diabetes (T2DM) Treatment in Venezuela: A Budget Impact Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PDB2 Systematic Literature Review of the Efficacy and Safety of Metformin Extended Release Relative to Metformin Immediate Release in the Treatment of Type 2 Diabetes Mellitus
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pdb38 - Budget Impact Analysis of Benaglutide Injection in the Treatment of Type 2 Diabetes in China
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Compliance and Efficacy of Extended Release Metformin and Immediate Release Thrice Daily Metformin in Type-2 Diabetes Mellitus- A Comparative Study
IOSR Journal of Dental and Medical Sciences
Profile of Saxagliptin in the Treatment of Type 2 Diabetes: Focus on Japanese Patients
Therapeutics and Clinical Risk Management
Budget Impact Analysis of Adding Dapaglifozin to the Therapy of Diabetes Mellitus Type 2 in Bulgaria
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Budget Impact Analysis of Biphasic Insulin Aspart in the Treatment of Type 2 Diabetes Mellitus in Malaysia: A Public Payer Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Use of Metformin and Vildagliptin for Treatment of Type 2 Diabetes in the Elderly
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Metformin Remains the Best Treatment for Type 2 Diabetes
BMJ
